Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.61 |
| ▸ | HPGD | P15428 | 1/20 | 0.61 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | HPGDS | O60760 | 1/20 | 0.45 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.44 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | CTSL | P07711 | 4/20 | 0.43 |
| ▸ | CTSS | P25774 | 2/20 | 0.43 |
| ▸ | CTSK | P43235 | 2/20 | 0.43 |
| ▸ | CTSB | P07858 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL8429009 | 0.80 | LMNA (0.65) | LMNAHPGDHDAC1SMN1; SMN2ALDH1A1 | |
| SCHEMBL8064650 | 0.79 | ALDH1A1 (0.43) | LMNAHPGDHDAC1SMN1; SMN2ALDH1A1 | |
| SCHEMBL530337 | 0.78 | LMNA (0.67) | LMNAHPGDHDAC1SMN1; SMN2ALDH1A1 | |
| SCHEMBL4164616 | 0.78 | LMNA (0.67) | LMNAHPGDHDAC1SMN1; SMN2ALDH1A1 | |
| SCHEMBL27882748 | 0.78 | LMNA (0.67) | LMNAHPGDHDAC1SMN1; SMN2ALDH1A1 | |
| SCHEMBL12104795 | 0.78 | LMNA (0.67) | LMNAHPGDHDAC1SMN1; SMN2ALDH1A1 | |
| SCHEMBL8108955 | 0.78 | LMNA (0.67) | LMNAHPGDHDAC1SMN1; SMN2ALDH1A1 | |
| SCHEMBL6277 | 0.78 | LMNA (0.67) | LMNAHPGDHDAC1SMN1; SMN2ALDH1A1 | |
| SCHEMBL1271236 | 0.78 | LMNA (0.67) | LMNAHPGDHDAC1SMN1; SMN2ALDH1A1 | |
| SCHEMBL9848415 | 0.78 | LMNA (0.53) | LMNAHPGDHDAC1SMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1114815-B1 | Process to prepare taxol | UPJOHN CO (US) | 2004-09-29 | — | — | EP | claimed |
| EP-1114815-A2 | Process to prepare taxol | PHARMACIA & UPJOHN COMPANY (US) | 2001-07-11 | — | — | EP | claimed |
| EP-0912504-A1 | PROCESS TO PREPARE TAXOL | PHARMACIA & UPJOHN COMPANY (US) | 1999-05-06 | — | — | EP | claimed |
| CN-1216039-A | Process for preparing taxol | UPJOHN CO (US) | 1999-05-05 | — | — | CN | claimed |
| WO-1997042167-A1 | PROCESS TO PREPARE TAXOL | PHARMACIA & UPJOHN COMPANY (US) | 1997-11-13 | — | — | WO | claimed |
| EP-1114815-B1 | Process to prepare taxol | UPJOHN CO (US) | 2004-09-29 | — | — | EP | disclosed |
| EP-1352900-A1 | Process to prepare taxol | PHARMACIA & UPJOHN COMPANY (US) | 2003-10-15 | — | — | EP | disclosed |
| EP-1352899-A1 | Process to prepare taxol | PHARMACIA & UPJOHN COMPANY (US) | 2003-10-15 | — | — | EP | disclosed |
| EP-0912504-B1 | Oxazolidine ester | UPJOHN CO (US) | 2002-09-11 | — | — | EP | disclosed |
| US-6307064-B1 | PHENYLISOSERINE ESTER OF SILYLATED BACCATIN III | PHARMACIA & UPJOHN COMPANY | 2001-10-23 | — | — | US | disclosed |
| EP-1114815-A2 | Process to prepare taxol | PHARMACIA & UPJOHN COMPANY (US) | 2001-07-11 | — | — | EP | disclosed |
| US-6177573-B1 | Process to prepare taxol | PHARMACIA & UPJOHN COMPANY | 2001-01-23 | — | — | US | disclosed |
| US-6057452-A | Process to prepare taxol | PHARMACIA & UPJOHN COMPANY | 2000-05-02 | — | — | US | disclosed |
| EP-0912504-A1 | PROCESS TO PREPARE TAXOL | PHARMACIA & UPJOHN COMPANY (US) | 1999-05-06 | — | — | EP | disclosed |
| CN-1216039-A | Process for preparing taxol | UPJOHN CO (US) | 1999-05-05 | — | — | CN | disclosed |
| WO-1997042167-A1 | PROCESS TO PREPARE TAXOL | PHARMACIA & UPJOHN COMPANY (US) | 1997-11-13 | — | — | WO | disclosed |